Enid News & Eagle

Lirum Therapeutics’ LX-101 New Positive Data Selected for Presentation at the 2025 American ...

New York, NY, April 29, 2025 (GLOBE NEWSWIRE) -- Lirum Therapeutics, Inc. (“Lirum”), an innovative clinical-stage biopharmaceutical company focused on the treatment of debilitating diseases, announced ...
manilatimes

Lirum Therapeutics Announces New LX-101 Data in Thyroid Eye Disease Selected for Presentation at the Association for Research in Vision and Ophthalmology (ARVO) 2025 Annual Meeting

New York, NY, May 07, 2025 (GLOBE NEWSWIRE) -- Lirum Therapeutics, Inc. ("Lirum”), an innovative clinical-stage biopharmaceutical company focused on the treatment of debilitating diseases, announced ...
Mena FN

Lirum Therapeutics’ LX-101 New Positive Data Selected For Presentation At The 2025 American Association For Cancer Research (AACR) Annual Meeting

(MENAFN- GlobeNewsWire - Nasdaq) New York, NY, April 29, 2025 (GLOBE NEWSWIRE) -- Lirum Therapeutics, Inc. (“Lirum”), an innovative clinical-stage biopharmaceutical company focused on the treatment of ...